inVentiv Health

The truth about global health

Monday, August 17, 2015

The Pulse on Global Trials by Matthew Howes

How you see the world depends on where you are. From one side of a room, the shadow of a cylinder may appear as a square; from the other side, a circle. Each perspective is true to the observer, but the truth is that both are correct.

[Read More]

Regulatory compliance is about to get more challenging in the E.U.

Monday, July 20, 2015

The Pulse on Global Trials by Matthew Howes

Last year, the European Union (E.U.) adopted new clinical trial regulation, E.U. CTR 536/2014, which is intended to clarify and standardize rules for conducting clinical trials across the region. The new regulation, scheduled to take effect in May 2016, repeals a directive issued by the European Parliament in 2001. It is unclear if the effect of the new rules will match their intent.

[Read More]

Digital messaging as a means of accelerating recruitment

Monday, June 22, 2015

The Pulse on Global Trials by Matthew Howes

Sourcing and retaining qualified subjects for clinical trials continues to be one of the biggest challenges researchers face. Nearly 80% of trials fail to meet enrollment timelines. What if we could accelerate recruitment and improve the trial experience through the application of simple and secure digital messaging? 

[Read More]

ClinTec International expands into South Africa

Monday, June 15, 2015

Global CRO ClinTec International has expanded with a Regional Hub Office for Sub-Saharan Africa in Johannesburg, South Africa. Aligning with new client partnerships, the office will support region wide clinical research services including a significant new clinical FSP assignment with a global biotechnology major where ClinTec is the sole FSP partner for South Africa. 

[Read More]

inVentiv Health names Michael McKelvey EVP, Clinical division president

Friday, June 5, 2015

Global CRO inVentiv Health has appointed Michael McKelvey, Ph.D., president, inVentiv Health Clinical Division, and executive vice president, inVentiv Health. McKelvey is a seasoned veteran within the CRO industry and has a strong background in clinical development, technology and the development of innovative industry strategies. McKelvey has extensive experience in building and managing successful global organizations in the pharmaceutical services, healthcare, information technologies, life sciences, technology and global core laboratory industries.  

[Read More]

CRI and Cancer Immunology

Monday, April 27, 2015

The Pulse on Global Trials by Matthew Howes

Since being named “Breakthrough of the Year” by Science magazine less than two years ago, cancer immunology has been taken from the fringe to the forefront. 

[Read More]